Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Topical tofacitinib is effective and safe for treating alopecia areata.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Stress hormone CRF causes hair loss and inhibits hair growth in human cells.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Minoxidil may help treat hair loss by reducing inflammation-related gene activity in skin cells.

Asparagus racemosus and Withania somnifera can help reduce side effects of a cancer drug.

Insulin resistance significantly contributes to the development and severity of certain chronic skin diseases.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Activating a protein called β-catenin in adult skin can make it behave like young skin, potentially helping with skin aging and hair loss.

Certain immune cells in the skin release a protein that stops hair growth by keeping hair stem cells inactive.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Probiotics show promise for health benefits but need more research to understand how they work.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Skin can produce blood cells, often due to disease, which might lead to new treatments for skin and blood conditions.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Hydra can help understand human hair follicle microbiomes and develop new skin disease therapies.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

PRP treatment may help with alopecia areata, especially in newer cases.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.